![Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice | Science Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice | Science](https://www.science.org/cms/asset/89e6733b-a5dd-4a07-9b5a-c89ccbb80a75/355_842_f1.gif)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice | Science
GitHub - LordNed/J3D-Model-Viewer: This project uses the JStudio library to load .bmd and .bdl models and apply bone and texture animations to them. It also emulates lighting and modification of the TEV
![Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial - eClinicalMedicine Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/7a30777c-53d2-492e-949d-a65774bf25da/gr1_lrg.jpg)
Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial - eClinicalMedicine
![Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial - The Lancet Oncology Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2001025463/2003895193/gr1.gif)
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial - The Lancet Oncology
![Cancers | Free Full-Text | Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Cancers | Free Full-Text | Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at](https://www.mdpi.com/cancers/cancers-14-03199/article_deploy/html/images/cancers-14-03199-g001.png)
Cancers | Free Full-Text | Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at
![Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice: Molecular Therapy Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice: Molecular Therapy](https://www.cell.com/cms/attachment/2108969368/2082729022/gr1.jpg)
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice: Molecular Therapy
![Reduction in Routine Labs in the Inpatient BMT Setting: A Quality Improvement Initiative - Biology of Blood and Marrow Transplantation Reduction in Routine Labs in the Inpatient BMT Setting: A Quality Improvement Initiative - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/6fb06a22-33a0-44bc-a6ae-9b0ca961b6ef/gr13_lrg.jpg)